Verma reports holding a Tier 1 Canada Research Chair in Cardiovascular Surgery and receiving grants, research support, and speaking honoraria from and acting as an advisor for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, the Canadian Heart Research Centre, the Canadian Medical and Surgical Knowledge Translation Research Group, Eli Lilly, HLS Therapeutics, Humber River Health, Janssen, Merck, Novartis, Novo Nordisk, Pfizer, PhaseBio, S & L Solutions Event Management, Inc, Sanofi, and Sun Pharma
[DOI] [PubMed] [Google Scholar] De Jager 2010 Jager J, Kooy A, Lehert P, Wulffel MG, Kolk J, Bets D, et al
1, 4 and 5 were created using BioRender

The daily agenda for the in-person event is as follows: 7:00 am 8:00 am: Breakfast 8:30 am 11:30 am: Ski Morning 12:00 pm 1:00 pm: Lunch 1:00 pm 2:40 pm: Session #1 2:40 pm 2:55 pm: Break #1 2:55 pm 4:35 pm: Session #2 4:35 pm 4:50 pm: Break #2 4:50 pm 6:30 pm: Session #3 (Day 2 only) 7:00 pm 9:00 pm: Reception Dinner & Networking December 5th 7:00 am 8:00 am: Breakfast 8:30 am 11:30 am: Ski Morning 12:00 pm 1:00 pm: Lunch 1:00 pm 2:40 pm: Session #1 2:40 pm 2:55 pm: Break #1 2:55 pm 4:35 pm: Session #2 4:35 pm 4:50 pm: Break #2 4:50 pm 6:30 pm: Session #3 December 6th 7:00 am 8:00 am: Breakfast 8:30 am 11:30 am: Ski Morning 12:00 pm 1:00 pm: Lunch 1:00 pm 2:40 pm: Session #1 2:40 pm 2:55 pm: Break #1 2:55 pm 4:35 pm: Session #2 4:35 pm 4:50 pm: Break #2 4:50 pm 6:30 pm: Session #3 7:00 pm 9:00 pm: Reception Dinner & Networking December 7th 7:00 am 8:00 am: Breakfast 8:30 am 11:30 am: Ski Morning 12:00 pm 1:00 pm: Lunch 1:00 pm 2:40 pm: Session #1 2:40 pm 2:55 pm: Break #1 2:55 pm 4:35 pm: Session #2 4:35 pm 4:50 pm: Break #2 4:50 pm 6:30 pm: Session #3 Other Questions

We believe that fibroblast-based cell therapy can be both clinically beneficial and commercially attractive for patients with the disease
Clinical Evidence on Efficacy of CJC-1295 Evidence regarding CJC-1295s efficacy is confined to small, early-phase studies, with no randomized controlled trials (RCTs) published between 20202026 specific to the peptide